All Phenotypes Cnr1<tm1Zim> MGI Mouse

• over time, mutants show an increase in spontaneous deaths, with more than 30% of mutants under 24 weeks of age dying

premature death ( J:54995 )

• over time, mutants show an increase in spontaneous deaths, with more than 30% of mutants under 24 weeks of age dying

• death is sudden with no signs of weight loss, dehydration, or abnormal posture

postnatal lethality, incomplete penetrance ( J:54995 )

• fewer than the expected numbers (23.3% vs. 29% expected) of homozygotes are seen at weaning, indicating some loss either during embryonic development or early postnatal life

early parturition ( J:144423 )

• mice exhibit preterm labor prior to day 19.6 of pregnancy compared with wild-type mice

impaired behavioral response to addictive substance ( J:54995 )

• mutants show no hypothermia, no hypoactivity, and no catalepsy after administration of HU210, a potent synthetic cannabinoid agonist or delta9-tetrahydrocannabinol (THC) and no delta9-THC-induced analgesia in the hotplate test

• mutants exhibit head bobbing, assume a hunched position after injection, lick their abdomens, and have strong diarrhea after delta9-THC injection, unlike wild-type which show pronounced hypoactivity

decreased vertical activity ( J:55294 )

• rearing rate is reduced drastically

decreased locomotor activity ( J:54995 , J:55294 )

• mutants are hypoactive in the open-field test (J:54995)

• mutants exhibit a reduction in locomotor activity, in both ambulation counts and ambulation time (J:55294)

• however, motor coordination on the rotarod appears normal (J:55294)

hypoalgesia ( J:54995 )

• hypoalgesia in hotplate and formalin tests

• responses are normal in the tail-flick test

increased chemical nociceptive threshold ( J:54995 )

• mutants show a reduced number of pain responses in the early phase of the formalin test

increased thermal nociceptive threshold ( J:54995 )

• mutants show increased response latencies in the hotplate test

catalepsy ( J:54995 )

• mutants spend longer time motionless in the ring catalepsy test compared to wild-type indicating an increase in ring catalepsy

increased circulating estradiol level ( J:144423 )

• on days 16 to 19 of pregnancy

increased circulating corticosterone level ( J:144423 )

• on days 14 to 16 of pregnancy

decreased circulating progesterone level ( J:144423 )

• on day 19 of pregnancy

increased follicle stimulating hormone level ( J:144423 )

• during late pregnancy

maternal effect ( J:144423 )

• newborns exhibit reduced birth weights compared to wild-type mice or newborns from homozygous females mated with wild-type mice

• however, treatment with a CRH-RI selective antagonist, antalarmin hydrochloride, on days 15 to 17 of pregnancy or progesterone on day 18 of pregnancy restores normal birth weights

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/17/2024 MGI 6.24